2026. Serum Adiponectin as a Diagnostic Marker of Early Renal Dysfunction in Patients with Hypertension and Type 2 Diabetes. Journal of Medical Sciences. 21, 1 (Jun. 2026), 22–28. DOI:https://doi.org/10.51984/18dd9796.